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THE CASE
A 21-year-old white male with a 3-year history 
of back pain that was worse after rest and associ-
ated with morning stiffness, was referred to the 
gastroenterology outpatients department with 
a 6-month history of weight loss (10 kg), leth-
argy and left hip pain, and diarrhea that had 
lasted 4 days. He denied having any other gastro-
intestinal symptoms and there was no relevant 
family history. On physical examination he 
appeared thin (BMI 18 kg/m2) and pale. Physical 
examination revealed only a reduced Schober’s 
index (the degree of lumbar forward flexion as 
a patient bends over and aims to touch their toes), a 
painful left hip and a reduced range of movement 
in both hips. 
Initial laboratory investigations revealed 
several abnormalities: a hemoglobin level of 
6.8 g/dl (normal range 13.5–17.7 g/dl) with 
iron deficiency, an erythrocyte sedimentation 
rate of 24 mm/h (normal rate <10 mm/h) and a 
C-reactive protein level of 36.9 mg/l (normal 
level <5 mg/l).
Plain radiography of the lumbosacral spine 
and pelvis revealed symmetrical erosive changes 
in both sacroiliac joints and squaring of the 
lumbar vertebrae, in keeping with a diagnosis 
of ankylosing spondylitis. In addition, there 
was asymmetrical loss of joint space and scle-
rosis in both hips, indicative of degenerative 
bone disease.
Further investigations detected a high fecal 
calprotectin level (300 mg/l, normal range 
<50 mg/l), which indicated that the patient had 
intestinal inflammation, but normal intestinal 
absorption-permeability (tested by absorption 
of 3-O-methyl-d-glucose, d-xylose, l-rhamnose 
and lactulose), which excluded the possibility 
that the patient had a malabsorption syndrome. 
Fecal and/or serological tests for infection 
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with most pathogenic strains of Salmonella, 
Shigella and Yersinia bacteria were negative. The 
results of a barium follow-through procedure 
were unremarkable.
Endoscopy (including a jejunal biopsy) 
revealed a macroscopically and histologically 
normal upper gastrointestinal tract; however, 
ileocolonoscopy revealed the presence of 
multiple aphthous ulcers in the terminal ileum, 
which was confirmed by capsule enteroscopy. 
Histology of the ileal biopsies revealed that 
the villi structure was distorted with focal 
lymphocytic cryptitis. The lamina propria was 
expanded with a chronic inflammatory cell infil-
trate, prominent lymphoid follicles and small, 
non caseating granulomas (Figure 1). There was 
limited infiltration of the lamina propria with 
neutrophils. Staining for acid-fast bacilli and 
fungi produced negative results. Colonic biop-
sies, the serum concentration of angiotensin-
converting enzyme, and chest and abdominal 
CT scans were all normal. 
The patient received a blood transfusion 
(5 units), was given oral iron supplements and 
put on an elemental diet for 6 weeks, in which 
time he gained 4 kg. Rheumatologists diag-
nosed ankylosing spondylitis (human leukocyte 
antigen (HLA)-B27 positive) and commenced 
treatment with nabumetone, a nonacidic 
NSAID (1 g twice daily), sulfasalazine (3 g daily) 
and high-dose prednisolone (30 mg daily) with 
the intention of decreasing the dose incremen-
tally once the patient’s appetite returned. He 
returned to full employment, but unfortunately 
failed to attend follow-up clinics. 
The patient presented again with severe, 
left-sided hip pain and limited hip and lumbar 
movement 2 years later, having continued 
treatment with sulfasalazine and the high-dose 
prednisolone but not with nabumetone. At this 
stage the ankylosing spondylitis was quiescent 
(clinically and serologically). Radiography of 
the pelvis showed severe degenerative changes, 
which necessitated bilateral hip replacement. 
Following postoperative recovery, when the 
patient was off all treatment for his ankylosing 
spondylitis, he underwent a repeat gastro-
intestinal investigation. The results of a barium 
follow-through procedure, capsule entero-
scopy, ileocolonoscopy with biopsies, measure-
ment of fecal calprotectin levels and routine 
hemato logical and biochemical laboratory 
investi gations were all normal. 
In view of the diagnosis of ankylosing spondy-
litis, the lack of intestinal symptoms and 
normal barium follow-through findings, ileo-
colonoscopy and ileal biopsy findings, a diag-
nosis of ileitis of spondylarthropathy was made. 
The patient is currently doing well 18 months 
after his double hip replacement. 
DISCUSSION OF DIAGNOSIS
In this case, the patient does not have features 
fully consistent with a diagnosis of Crohn’s 
disease. The presentation is more in keeping with 
a diagnosis of ileitis of spondylarthropathy. It 
can be difficult to distinguish between these two 
diagnoses—the two main distinctions being that 
ileitis of spondylarthropathy is asymptomatic and 
that it does not lead to radiologically detectable 
abnormalities of the terminal ileum.1 
Ankylosing spondylitis is but one form of 
the HLA-B27-positive spondylarthropathies, 
which include psoriatic arthritis, Reiter’s 
syndrome, enteropathic arthritis, Behçet’s 
disease and juvenile idiopathic arthritis.2 The 
association between the HLA-B27- positive 
spondyl arthropathies and subclinical ileal 
inflammation varies. Ileitis associated with 
ankylosing spondy litis is the best-characterized 
association and it cannot be distinguished easily 
from Crohn’s disease, either macroscopically 
or micro scopically. As the ileitis provides prog-
nostic information on the course of the arthritis 
and can guide treatment, there is a rationale for 
Figure 1 Histological image from the ileal biopsy 
of a 21-year-old patient taken at diagnosis of 
ankylosing spondylitis associated with ileitis 
of spondylarthropathy. A dense, chronic, 
inflammatory cell infiltrate, lymphoid follicles 
and a granuloma (between the arrows) can be 
seen. These clinical signs are equally prevalent 
in patients with small-bowel Crohn’s disease and 
ankylosing spondylitis.
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patients with active ankylosing spondylitis to 
undergo ileocolonoscopic examination.3 
From a researcher’s point of view, the inter-
action between intestinal inflammation and 
arthropathy is a fascinating one. In this patient, 
the activity of his arthritis correlated with the 
degree of intestinal inflammation, similar to 
the effect seen in transgenic rats engineered 
to over express genes encoding human HLA-B27 
and β2 microglobulin, where the activity of the 
arthritis is proportional to the colonic inflam-
mation.1 In asymptomatic relatives of patients 
with ankylosing spondylitis there is a significant 
correlation between the presence of subclinical 
intestinal inflammation and early features of 
ankylosing spondylitis as seen on spiral CT, 
which suggests that the ileitis and arthritis 
are causally related.4 It has been suggested 
that ileitis of spondylarthro pathy represents 
subclinical Crohn’s disease that does not prog-
ress to overt Crohn’s disease in the majority of 
patients because of a lack of genetic or environ-
mental factors.3,5–7  If this group do have 
subclinical Crohn’s disease they would seem an 
ideal patient group in which to study the early 
pathogenic events in Crohn’s disease. Studies 
published in the last 5 years indeed show some 
very interesting relationships between Crohn’s 
disease and ankylosing spondylitis. For example, 
half of all first-degree relatives of patients with 
either Crohn’s disease or ankylosing spondy-
litis have subclinical intestinal inflammation 
that is inherited according to an additive trait 
(there are a number of genes that influence 
the risk of developing this inflammation and the 
more of these variants a patient has the more 
severe their phenotype).4,8 By analysis of the 
Icelandic genealogy database and population-
wide data from all living Icelanders diagnosed 
with Crohn’s disease and ankylosing spondy-
litis it was shown that both disorders have high 
heritability scores and that the patients with 
both diseases are significantly more closely 
related than controls.9 This finding suggests 
that there are one or more common, and as yet 
undiscovered, genetic variants that underlie the 
predisposition to both diseases.
DIFFERENTIAL DIAGNOSIS
On the basis of the clinical history, signs and 
symptoms and laboratory findings there is 
little doubt about the diagnosis of ankylosing 
spondylitis in this case. Given the presence of 
an associ ated granulomatous ileitis (which has 
many potential causes), however, there is a wide 
differential diagnosis.
Infectious causes
Some intestinal infections are associated with 
the development of arthritis and, although there 
is a time delay between the infection and the 
occurrence of a peripheral arthropathy, spondy-
larthropathy following intestinal infection is not 
rare. Salmonella spp. and Shigella spp. can cause 
arthritis, but are not associated with intestinal 
granuloma. Yersinia spp. are associated with 
a granulomatous ileitis10 and reactive arthritis 
(in HLA-B27-positive individuals) with some 
of the features of a spondylarthropathy. In this 
case, however, the patient had not been to an 
area endemic for Yersinia spp. and serology for 
these bacteria was negative.
Intestinal tuberculosis causes large ileocecal 
ulcers (and strictures). The findings that argue 
against a diagnosis of intestinal tuberculosis 
in this patient were the normal chest X-ray 
images (frequently cited as evidence against 
intestinal tuberculosis in white patients), the 
small, noncaseating granulomas and the fact 
that there was no dissemination of tuberculosis 
when high-dose steroids were initiated. 
Intestinal sarcoidosis (an infectious cause is 
not proven) is very rare and usually patients 
present with respiratory, skin and eye symptoms. 
Lymphatic obstruction, which this patient did 
not have, is a characteristic intestinal finding of 
this condition. Furthermore, the normal level 
of angiotensin-converting enzyme makes this 
diagnosis very unlikely. Measles can cause a 
granulomatous ileitis, but this ileitis occurs in 
the setting of disseminated disease.
NSAID enteropathy
Most patients with ankylosing spondylitis are 
treated with NSAIDs, which causes inflamma-
tion of the small intestine (NSAID enteropathy) 
with small-bowel ulcers.11 NSAID entero-
pathy is usually asymptomatic, although some 
patients present with iron deficiency anemia, 
perforation or strictures (the presence of which 
is termed ‘diaphragm disease’ and is patho-
gnomonic for NSAID enteropathy). Although 
NSAID enteropathy cannot be entirely ruled 
out in this case, localization of NSAID entero-
pathy to the terminal ileum (rather than mid-
small bowel) would be unusual and there 
have been no reports of granulomatous reac-
tions in intestinal biopsies from patients with 
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NSAID enteropathy.1 Capsule enteroscopy 
has facilitated the diagnosis of NSAID entero-
pathy, but the small-bowel images obtained 
do not distinguish NSAID enteropathy from 
a diagnosis of Crohn’s disease or the ileitis of 
spondyl arthropathy (Figure 2). 
Crohn’s ileitis
Crohn’s disease cannot be completely excluded 
in this case. The spondylarthropathy associated 
with Crohn’s disease can only be distinguished 
from idiopathic ankylosing spondylitis by the 
prevalence of HLA-B27, which, while still high, 
is significantly lower in patients with Crohn’s 
disease than in those with ankylosing spondy-
litis.1 Classic IBD, however, precedes the develop-
ment of spondylitis in most cases. On the other 
hand, patients with established spondylarthro-
pathy (<5%) can develop classic IBD within 
10 years of the primary diagnosis: in this case, 
80% of patients develop Crohn’s disease and 
20% ulcerative colitis.3 Curiously, the main risk 
factor for IBD in patients with established anky-
losing spondylitis is the absence of HLA-B27 
(80% of cases).7 In this patient, a number of 
findings argued against a diagnosis of Crohn’s 
disease: the lack of gastrointestinal symptoms; 
the very modest increase in the concentration 
of fecal calprotectin and its subsequent normali-
zation (most patients with quiescent Crohn’s 
disease have raised fecal calprotectin levels); 
the failure of the disease to show radiologically 
visible progression; and the resolution of the 
macroscopic and histological ileal findings.
Ileitis associated with ankylosing 
spondylitis
The prevalence of intestinal inflammation in 
patients with ankylosing spondylitis is much 
higher than the 1–6% prevalence of anky-
losing spondylitis in patients with IBD.12 
Ileocolonoscopy reveals subclinical intestinal 
inflammation in approximately 60% of patients 
with ankylosing spondylitis,3,7,13 predominantly 
in the terminal ileum, although some studies 
suggest that microscopic colitis is equally prev-
alent. The gut lesions found in patients with 
ileitis associated with ankylosing spondylitis 
are divided histologically into acute (neutrophil 
dominant) or chronic (lymphocyte dominant). 
The chronic form closely resembles ileal Crohn’s 
disease as it is characterized by the same preva-
lence of granulomas.1 The presence of chronic 
ileal lesions predict an aggressive evolution of 
the arthritis.5,7,14
Successful treatment of the joint inflamma-
tion is associated with normal macroscopic and 
microscopic ileal findings at repeat ileocolono-
scopy. By contrast, patients who continue to 
experience joint inflammation have persistent 
gut inflammation.3,7 
TREATMENT AND MANAGEMENT
If this patient had been compliant with follow-
up, it is probable that he would have been spared 
long-term treatment with cortico steroids. 
Nevertheless, the granulomatous chronic ileal 
inflammation detected on the initial biopsy 
correctly predicted that the patient had an 
A B C
Figure 2 Wireless capsule enteroscopy images used in the differential diagnosis of ileitis. The images demonstrate the difficulty in 
distinguishing between the ileitis associated with spondylarthropathy, NSAID ingestion and Crohn’s disease. (A) Ileal ulcer in a patient 
with spondylarthropathy who had not received NSAIDs, (B) Ileal ulcers in a volunteer who had received diclofenac sodium (150 mg daily 
for 10 days) and (C) Ileal ulcers in a patient with Crohn’s disease.
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aggressive, treatment-resistant form of spondylo-
arthropathy, which might have called for early 
intervention with antitumor-necrosis-factor 
therapy.15 Treatment with sulfasalazine was 
appropriate because 46% of spondyl arthropathy 
patients who receive sulfasalazine achieve 
a peripheral locomotor remission with this 
drug.5 It is uncertain whether 5-aminosalicylic 
acid preparations would have the same effect as 
sulfasalazine itself, because it is the sulfapyridine 
moiety of sulfasalazine that is the active compo-
nent in patients with other arthropathies such as 
rheumatoid arthritis.16 
CONCLUSIONS
Firstly, this case is important as a reminder that 
there is a wide differential diagnosis for granulo-
matous ileitis, even though the vast majority of 
such cases will be associated with Crohn’s disease. 
Secondly, there is a rationale for carrying out 
ileocolonoscopy on patients with newly diag-
nosed ankylosing spondylitis as the ileal biop-
sies could give prognostic information on the 
arthropathy. Lastly, there is emerging evidence 
that ileitis of spondylarthropathy might repre-
sent subclinical Crohn’s disease. The relationship 
between the two diseases will be of particular 
interest to research workers in IBD, as targeted 
research in spondylarthropathy could unravel 
the early pathogenic events in Crohn’s disease.
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